Two hugely important public health objectives – Black Lives Matter and COVID-19 have been framed as competing imperatives. They are not. The Black Lives Matter movement in Australia seeks to highlight the deplorable circumstances of disadvantage and discrimination experienced by Australia’s First people.
Australia’s response to COVID-19 so far, has been one of the better examples globally: consistently led by medical and scientific advice. It was bipartisan, cooperative and decisive. Yet, this success has come at significant costs.
The fires, floods and COVID-19 pandemic have shown the fragility of industrial civilisation and the strength and resilience of people and community.
State governments are planning to reopen pokie venues due to heavy lobbying by the gambling industry. However, there a number of public health issues which need to be addressed to ensure reopening these venues will not endanger the health of those who use or work there.
As coronavirus restrictions continue to ease, one of the key challenges we face is how to deal with people moving around a lot more.
Many jurisdictions around the world are now testing people without symptoms as part of efforts to manage COVID-19. In Victoria, asymptomatic health-care workers have been part of the recent “testing blitz”.
The recently created National COVID-19 Coordination Commission has been set up to advise on all non-health aspects on the pandemic. But there are serious concerns about its scope, membership and authority.
For many of us, forced to work at home or to not work at all, the COVID-19 crisis has driven home the importance of mental health and how work interacts with our sense of wellbeing.
Major cities and their birds are breathing easier. Across China, smog has given way to the colour blue. Even the snow-capped Himalayas are visible from parts of Northern India for the first time in local’s memories.
Imagine you have just been told you have COVID-19. We know this is infectious, so the chances are, you may well have given it to others already.
Patents and related intellectual property rights can present formidable barriers to procuring medicines, vaccines, diagnostic tests and medical devices.